Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Home
Current IssueAccepted ManuscriptsAll IssuesIn Press ArticlesSearch
Instructions
Journal InformationBoards and committeesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Crossref

1. Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin

- Masanori Atsukawa

- Akihito Tsubota

- Noritomo Shimada

- Kai Yoshizawa

- Hiroshi Abe

- Toru Asano

- Yusuke Ohkubo

- Masahiro Araki

- Tadashi Ikegami

- Tomomi Okubo

- Chisa Kondo

- Yuji Osada

- Katsuhisa Nakatsuka

- Yoshimichi Chuganji

- Yasushi Matsuzaki

- Katsuhiko Iwakiri

- Yoshio Aizawa

2. Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C

- Masanori Atsukawa

- Akihito Tsubota

- Noritomo Shimada

- Hiroshi Abe

- Chisa Kondo

- Norio Itokawa

- Ai Nakagawa

- Katsuhiko Iwakiri

- Chiaki Kawamoto

- Yoshio Aizawa

- Choitsu Sakamoto

3. Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients

- Masanori Atsukawa

- Akihito Tsubota

- Noritomo Shimada

- Kai Yoshizawa

- Hiroshi Abe

- Toru Asano

- Yusuke Ohkubo

- Masahiro Araki

- Tadashi Ikegami

- Chisa Kondo

- Norio Itokawa

- Ai Nakagawa

- Taeang Arai

- Yoko Matsushita

- Katsuhisa Nakatsuka

- Tomomi Furihata

- Yoshimichi Chuganji

- Yasushi Matsuzaki

- Yoshio Aizawa

- Katsuhiko Iwakiri

4. Vitamin D supplementation for chronic liver diseases in adults

- Goran Bjelakovic

- Dimitrinka Nikolova

- Marko Bjelakovic

- Christian Gluud

5. Randomized study comparing vitamin D3 and 1α‐Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C

- Yoshie Omori‐Mizuno

- Nobuaki Nakayama

- Mie Inao

- Junji Funyu

- Shinichi Asabe

- Kengo Tomita

- Kou Nishikawa

- Yasuo Hosoda

- Masahiko Tanaka

- Yoshiaki Hashimoto

- Koji Yakabi

- Yohei Koshima

- Satoshi Mochida

6. Pathology Predictors of Response to Combined Therapy of Chronic HCV Patients; Is it Applicable in the DAA Era?

- Samar Kamal Darweesh

7. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?

- Chao-Nan Jin

- Jing-Dan Chen

- Ji-Fang Sheng

8. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: A systematic review and meta-analysis

- Matthew T. Kitson

- Christoph Sarrazin

- Pierluigi Toniutto

- Guy D. Eslick

- Stuart K. Roberts

9. The Relationship Between 25-Hydroxyvitamin D3 and Hepatitis B Surface Antigen Levels in Patients with Chronic Hepatitis B in Japan

- Norio Itokawa

- Masanori Atsukawa

- Akihito Tsubota

- Hiroshi Abe

- Noritomo Shimada

- Tomomi Okubo

- Taeang Arai

- Ai Nakagawa

- Chisa Kondo

- Yoshio Aizawa

- Katsuhiko Iwakiri

10. Development of Interferon-Free, Direct-Acting Antivirals Treatment for Japanese Patients with Chronic Hepatitis C Infection and Chronic Kidney Disease

- Masanori Atsukawa

- Chisa Kondo

- Tadamichi Kawano

- Tomomi Okubo

- Taeang Arai

- Ai Nakagawa-Iwashita

- Norio Itokawa

- Katsuhiko Iwakiri

11. Vitamin D supplementation for chronic liver diseases in adults

- Milica Bjelakovic

- Dimitrinka Nikolova

- Goran Bjelakovic

- Christian Gluud

12. Roles of active forms of vitamin D in supporting innate immune systems and in reducing excess inflammation in COVID-19

- Olga A. Gromova

- Ivan I. Torshin

- Alexander G. Chuchalin

- Elena N. Kozhevnikova

- Svetlana I. Malyavskaya